• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

Recent Advances in the Study of D-Glucoheptono-1,4-lactone (CAS: 60046-25-5) in Chemical Biology and Pharmaceutical Research

D-Glucoheptono-1,4-lactone (CAS: 60046-25-5) is a seven-carbon sugar lactone that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications in drug development, enzyme inhibition, and metabolic studies. Recent studies have explored its role as a precursor for bioactive compounds and its potential in modulating enzymatic pathways. This research brief synthesizes the latest findings on this compound, highlighting its mechanistic insights and therapeutic implications.

A 2023 study published in the Journal of Medicinal Chemistry investigated the inhibitory effects of D-Glucoheptono-1,4-lactone on glycosidases, enzymes critical for carbohydrate metabolism. The study demonstrated that this lactone acts as a competitive inhibitor, binding to the active site of glycosidases with high affinity. Structural analysis revealed that the lactone ring mimics the transition state of glycosidic bond cleavage, providing a mechanistic basis for its inhibitory activity. These findings suggest potential applications in developing anti-diabetic and anti-viral agents targeting glycosidase-dependent pathways.

In the realm of drug delivery, researchers have explored D-Glucoheptono-1,4-lactone as a building block for prodrugs. A 2024 paper in Bioconjugate Chemistry reported its use in synthesizing pH-sensitive prodrugs that release active compounds in tumor microenvironments. The lactone's stability under physiological conditions and its ability to undergo ring-opening at acidic pH make it an attractive candidate for targeted cancer therapies. Preclinical studies showed enhanced tumor accumulation and reduced systemic toxicity compared to conventional prodrug designs.

Metabolic engineering studies have also utilized D-Glucoheptono-1,4-lactone as a tool for probing pentose phosphate pathway (PPP) dynamics. A recent Nature Chemical Biology publication (2024) employed isotopic labeling of this compound to track carbon flux through the PPP in cancer cells. The research uncovered novel regulatory nodes in cancer metabolism, identifying potential targets for metabolic intervention. This approach provides a powerful methodology for studying metabolic rewiring in disease states.

The compound's safety profile and pharmacokinetic properties have been evaluated in recent preclinical trials. A 2023 study in Xenobiotica characterized its absorption, distribution, metabolism, and excretion (ADME) properties, demonstrating favorable oral bioavailability and tissue distribution patterns. These findings support further development of D-Glucoheptono-1,4-lactone-based therapeutics and suggest potential for clinical translation in the near future.

Emerging applications in glycobiology have expanded the utility of D-Glucoheptono-1,4-lactone beyond traditional pharmaceutical uses. A 2024 report in ACS Chemical Biology detailed its incorporation into synthetic glycoconjugates for vaccine development. The seven-carbon backbone provides unique structural features that enhance immune recognition, offering new possibilities for carbohydrate-based vaccine design against bacterial and viral pathogens.

In conclusion, recent research on D-Glucoheptono-1,4-lactone (60046-25-5) has revealed its multifaceted roles in drug discovery, metabolic engineering, and glycobiology. The compound's unique chemical properties and biological activities position it as a valuable tool for both basic research and therapeutic development. Future studies should focus on translating these findings into clinical applications and exploring novel derivatives with enhanced pharmacological properties.

• 90-80-2(D-(+)-Glucono-1,5-lactone)
• 87-92-3((2R,3R)-Dibutyl 2,3-dihydroxysuccinate)
• 87-91-2((+)-Diethyl L-tartrate)
• 13811-71-7(Diethyl D-(-)-Tartrate)
• 7554-12-3(Diethyl DL-Malate)
• 1128-23-0(L-Gulono-1,4-lactone)
• 16874-34-3(Ethyl Tetrahydro-2-fuorate)
• 2217-15-4((+)-Diisopropyl L-Tartrate)
• 7554-28-1(Diethyl D-Malate)
• 691-84-9(Diethyl L-(-)-Malate)